Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 1946.00 -1.25 (-0.06%) | NSE 1945.70 -0.50 (-0.03%) | Trade | Add

BSE Live

Dec 01, 11:26

1946.00 -1.25 (-0.06%)

Volume

AVERAGE VOLUME

5-Day

23,735

10-Day

33,225

30-Day

41,218

17,070

Prev. Close

1947.25
Open Price

1940.15

Bid Price (Qty.)
1944.70 (34)
Offer Price (Qty.)
1945.65 (1)

NSE Live

Dec 01, 11:26

1945.70 -0.50 (-0.03%)

Volume

AVERAGE VOLUME

5-Day

1,048,276

10-Day

1,630,708

30-Day

1,044,547

244,833

Prev. Close

1946.20
Open Price

1950.00

Bid Price (Qty.)
1945.10 (9)
Offer Price (Qty.)
1945.80 (100)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	48.00	57.49	35.95	75.86	52.87
Diluted EPS (Rs.)	48.00	57.49	35.94	75.84	52.86
Cash EPS (Rs.)	52.91	61.25	40.14	79.58	56.14
Book Value [ExclRevalReserve]/Share (Rs.)	468.73	423.22	368.27	334.43	261.06
Book Value [InclRevalReserve]/Share (Rs.)	468.73	423.22	368.27	334.43	261.06
Dividend / Share(Rs.)	2.50	2.00	2.00	2.00	2.00
Revenue from Operations/Share (Rs.)	237.89	223.44	227.94	286.90	216.73
PBDIT/Share (Rs.)	67.73	63.90	54.15	107.98	66.72
PBIT/Share (Rs.)	62.82	60.13	49.96	104.26	63.18
PBT/Share (Rs.)	54.39	64.44	43.19	90.47	61.90
Net Profit/Share (Rs.)	48.00	57.49	35.95	75.86	52.60
Profitability Ratios
PBDIT Margin (%)	28.46	28.59	23.75	37.63	30.78
PBIT Margin (%)	26.40	26.91	21.91	36.34	29.15
PBT Margin (%)	22.86	28.83	18.94	31.53	28.56
Net Profit Margin (%)	20.17	25.72	15.77	26.44	24.27
Return on Networth / Equity (%)	10.24	13.58	9.76	22.68	20.15
Return on Capital Employed (%)	10.70	11.41	10.77	24.45	20.13
Return on Assets (%)	7.14	9.46	6.64	15.28	14.67
Total Debt/Equity (X)	0.27	0.26	0.29	0.29	0.11
Asset Turnover Ratio (%)	35.41	36.77	42.13	57.82	60.46
Liquidity Ratios
Current Ratio (X)	1.85	2.25	2.69	3.02	1.69
Quick Ratio (X)	1.50	1.85	2.18	2.44	1.33
Inventory Turnover Ratio (X)	8.02	6.92	5.79	7.07	6.32
Dividend Payout Ratio (NP) (%)	5.02	4.19	6.69	3.17	4.57
Dividend Payout Ratio (CP) (%)	4.55	3.93	5.99	3.02	4.28
Earnings Retention Ratio (%)	94.98	95.81	93.31	96.83	95.43
Cash Earnings Retention Ratio (%)	95.45	96.07	94.01	96.98	95.72
Valuation Ratios
Enterprise Value (Cr.)	9,299.62	21,093.48	17,678.28	26,727.49	23,125.14
EV/Net Operating Revenue (X)	1.39	3.35	2.75	3.30	3.78
EV/EBITDA (X)	4.87	11.70	11.57	8.77	12.28
MarketCap/Net Operating Revenue (X)	0.87	2.89	2.31	2.99	3.66
Retention Ratios (%)	94.97	95.80	93.30	96.82	95.42
Price/BV (X)	0.44	1.53	1.43	2.56	3.04
Price/Net Operating Revenue	0.87	2.89	2.31	2.99	3.66
Earnings Yield	0.23	0.09	0.07	0.09	0.07